Healthcare data company IMS Health files for an IPO that could raise upwards of $750 million


Shutterstock photo

IMS Health, which provides healthcare data and consulting services to drug makers, payers and healthcare providers, filed on Thursday with the SEC to raise up to $100 million in an initial public offering, although that amount is likely just a placeholder. We estimate the deal will raise between $750 million and $1 billion. The Danbury, CT-based company, which was founded in 1954 and booked $2.5 billion in sales for the 12 months ended September 30, 2013, plans to list on the NYSE under the symbol IMS. J.P. Morgan, Goldman Sachs and Morgan Stanley are the joint bookrunners on the deal. No pricing terms were disclosed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by